Baxter at the Edge: A Measured Rebound Trade from $17.95
Baxter (BAX) cratered after conservative 2026 guidance and a disappointing Q4 2025 EPS print. The stock is now trading near its 52-week low at $17.95 with attractive valuation metrics (market cap ~$9.24B, P/S ~0.85, P/B ~1.56) and positive free cash flow. This trade idea argues for a tactical long on weakness with a clear stop and a mid-term target…